Livongo IPO gives confidence boost to Asia's digital health scene
Investors could be more bullish on exit viability, business model of similar Asian digital health players
Add BT as a preferred source
Sharanya Pillai
Singapore
THE exuberant market response to the listing of US-based startup Livongo Health could provide a shot in the arm for Asian startups similarly focused on behavioural and preventive medicine, reckon investors who spoke to The Business Times.
Livongo, which debuted on the Nasdaq on Thursday, saw its share price surge 36 per cent to US$38.10 on the first day of trading, giving it a market cap of US$3.46 billion. This is more than four times its US$800 million valuation as at April.
TRENDING NOW
Lamborghini-driving boss of Eminent Frog Porridge charged with S$3.8 million tax evasion, money laundering
TikTok slashes content moderation teams globally; Singapore among markets affected
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
Sembcorp shares fall to four-month low; Citi cuts profit forecasts
